Surgical Innovations Group PLC (SUN), the UK-listed medical devices company, has disclosed a major shareholding notification filed on 18 November 2026 following a movement in voting rights on 16 November 2026. Gordon Lawrence Alan Dow, holding shares through Manchester-based nominee vehicle Lawshares Nominees, has increased his position from 3.27% to 4.72% of the company's total voting rights. The acquisition brings Dow's directly held ordinary shares to 44,000,000, up from 30,480,000, representing a meaningful increase in his exposure to the AIM-listed surgical device specialist.
Key Points
- Surgical Innovations Group PLC (SUN) — UK-listed medical devices manufacturer
- Gordon Lawrence Alan Dow increased his voting rights stake from 3.27% to 4.72% via Lawshares Nominees
- Total shares held rose to 44,000,000 ordinary shares; threshold crossed on 16 November 2026; issuer notified 18 November 2026
- Investors may watch whether further acquisitions push Dow's position above the next notifiable threshold, based on total voting rights of 932,816,177
Gordon Dow Crosses New Threshold with 44 Million Ordinary Shares in Surgical Innovations
The TR-1 standard notification form, completed on 18 November 2026 from Paphos, Cyprus, confirms that Gordon Lawrence Alan Dow crossed a notifiable threshold in Surgical Innovations Group PLC on 16 November 2026. All 44,000,000 voting rights are held directly under ISIN GB0004016704 as ordinary shares, with no indirect holdings and no financial instruments such as options or convertibles disclosed. The previous notification recorded a holding of 30,480,000 shares, equating to 3.27%, meaning the transaction added approximately 13,520,000 shares to his position, though the consideration paid was not disclosed in the announcement.
Lawshares Nominees in Manchester Named as Registered Shareholder for Dow's Surgical Innovations Position
The notification identifies Lawshares Nominees, registered in Manchester, United Kingdom, as the shareholder of record through which Dow holds his interest. The use of a nominee structure is a standard arrangement for holding listed securities in the UK and does not, by itself, indicate any change in beneficial ownership intentions. Dow is identified as the person subject to the notification obligation, with the filing completed from Paphos, Cyprus. No ultimate controlling undertaking separate from Dow himself is detailed in section nine of the TR-1 form submitted to Surgical Innovations Group PLC.
Surgical Innovations Group Total Voting Rights Base of 932,816,177 Provides Context for Stake Size
The announcement states that all percentage figures are calculated against a total voting rights figure of 932,816,177 shares in issue for Surgical Innovations Group PLC. At 4.72%, Dow's holding of 44,000,000 shares positions him as a notable individual shareholder in the company. Surgical Innovations Group, headquartered in the UK, develops and manufactures minimally invasive surgical instruments and devices, supplying healthcare markets. Investors may be watching whether this accumulation signals growing conviction in the company's strategic direction, though no commentary from Dow or the company was included in the notification.




Please wait processing your request...